Seller record · Telehealth service

SynergenX

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 5 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named on the weight-loss, peptide, telemedicine or privacy pages. 4 more criteria also fail; see the table below.

At a glance

SynergenXTelehealth service

3/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: compounded semaglutide injection, and 4 more
FDA letters: None on file

Visit SynergenX See all eight dispositions

Telehealth service. Passes 3 of 8 criteria. Recorded against Standard v1.1.

A chain of hormone clinics in Texas and the Chicago area, with telemedicine visits, offering compounded semaglutide and other GLP-1 weight-loss treatment, testosterone and hormone therapy, and sermorelin and PT-141 peptide therapy. It prints no price for its GLP-1 treatment, and no page says a compounded drug is not FDA-approved.

Operating entity SynergenX Health Holdings LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	SynergenX's weight loss for men page; SynergenX's weight loss page
S2	Prescription gating	PASS	SynergenX's weight loss for men page; SynergenX's weight loss page
S3	Pharmacy identification	FAIL	SynergenX's weight loss for men page; SynergenX's sermorelin HGH therapy page; SynergenX's privacy policy
S4	Compounding disclosure	FAIL	SynergenX's weight loss for men page; SynergenX's weight loss page; SynergenX's PT-141 peptide page
S5	Analytical documentation	FAIL	SynergenX's weight loss for men page; SynergenX's sermorelin HGH therapy page
S6	Business address	FAIL	SynergenX's privacy policy; SynergenX's houston galleria page
S7	Price disclosure	FAIL	SynergenX's weight loss for men page; SynergenX's telemedicine page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified provider reviews each patient's symptoms, goals and medical history in a consultation, and the weight-loss pages say all medications are prescribed based on lab results and clinical review.Source: SynergenX's weight loss for men page; SynergenX's weight loss page.

S2PASSEvery booking button leads to an appointment request, and the weight-loss pages say treatment starts with a consultation or a full evaluation with a provider, with medication prescribed only after lab results and clinical review.Source: SynergenX's weight loss for men page; SynergenX's weight loss page.

S3FAILNo filling pharmacy is named on the weight-loss, peptide, telemedicine or privacy pages.Source: SynergenX's weight loss for men page; SynergenX's sermorelin HGH therapy page; SynergenX's privacy policy.

S4FAILThe weight-loss pages offer a compounded formulation of semaglutide, and none of the weight-loss, peptide or policy pages states that a compounded drug is not FDA-approved.Source: SynergenX's weight loss for men page; SynergenX's weight loss page; SynergenX's PT-141 peptide page.

S5FAILNo certificate of analysis or lot document is published on the weight-loss, peptide or policy pages.Source: SynergenX's weight loss for men page; SynergenX's sermorelin HGH therapy page.

S6FAILThe privacy policy prints conflicting Houston addresses: 130 Vintage Park Blvd., Building C, Suite H, Houston, TX 77070 as its postal address, and 11445 Compaq Center West Dr., Houston, Texas beside SynergenX Health Holdings LLC. The clinic pages print their own addresses in Texas and Illinois.Source: SynergenX's privacy policy; SynergenX's houston galleria page.

S7FAILNo price for GLP-1 treatment is printed. The weight-loss pages price only the first appointment, a free consultation or a $100 full evaluation, and telemedicine visits are $59 for cash-pay patients.Source: SynergenX's weight loss for men page; SynergenX's telemedicine page.

S8PASSNo FDA warning letter names SynergenX or SynergenX Health Holdings LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, GLP-1 and GLP-1/GIP weight-loss treatment, lipotropic and B12 injections, sermorelin, PT-141.

Other sellers of the same products

Who sells semaglutide Who sells sermorelin Who sells PT-141

Visit SynergenX

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.